Open AccessLong-term survival after fludarabine, cyclophosphamide, and rituximab treatment in previously untreated chronic lymphocytic leukemia patients
Author(s) -
ShokhanMohammad Mustafa,
AhmedKhudair Yassin,
Nawsherwan Sadiq Mohammad,
RawandP Shamoon,
MarwaN Karam,
ShlanS Mohammad,
LaraLateef Abdulrahman,
ZhallaO Ahmed,
BryarSabah Rashid,
TavanI Mahmood,
Rozh-hatA Yousif,
KawaM Hasan,
ZekiA Mohamed,
HishamA Getta,
SanaD Jalal,
DanaA Abdullah,
BasilK Abdulla,
GhanimS Numan,
Ranan Karadagh
Publication year - 2021
Publication title -
iraqi journal of hematology
Language(s) - English
Resource type - Journals
eISSN - 2543-2702
pISSN - 2072-8069
DOI - 10.4103/ijh.ijh_22_21
Subject(s) - fludarabine , medicine , rituximab , cyclophosphamide , chronic lymphocytic leukemia , regimen , immunotherapy , chemoimmunotherapy , oncology , chemotherapy , leukemia , cancer , lymphoma
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom